Shortage-driven safety waivers

Updated: 2025.08.12 6M ago 1 sources

Regulators override quality enforcement and import bans for essential drugs during shortages, shifting risk to patients and relying on manufacturer self-testing. — It forces a public reckoning over safety vs. availability tradeoffs, transparency standards, and whether to re-shore or diversify drug supply to reduce reliance on opaque emergency exemptions.

Sources

The FDA Let Substandard Factories Ship These Medications to the U.S.

by Debbie Cenziper and Megan Rose, ProPublica, and Katherine Dailey, Medill Investigative Lab 2025.08.12 100% relevant

ProPublica details 150+ exemptions since 2013 that let drugs from banned foreign plants enter the U.S. without regular FDA testing or proactive adverse-event monitoring, with the exemptions largely hidden from the public.

← Back to All Ideas